Open AccessDeveloping Induced Pluripotent Stem Cell‐Based Therapy for the Masses
Author(s) -
Rao Mahendra S.,
Atala Anthony
Publication year - 2016
Publication title -
stem cells translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.781
H-Index - 71
eISSN - 2157-6580
pISSN - 2157-6564
DOI - 10.5966/sctm.2015-0184
Subject(s) - induced pluripotent stem cell , stem cell , cell therapy , stem cell therapy , biology , computational biology , microbiology and biotechnology , embryonic stem cell , genetics , gene
Realizing the potential of induced pluripotent stem cell therapy requires the development of processes that are reliable, reproducible, and cost‐effective and that at the same time do not compromise the safety of the individuals receiving this therapy. How cost reductions can be realized, using previous experience with obtaining approval of biologic agents, autologous therapy, and the recent approval of cord blood banks, is presented.